BioSpace News Archive

Business

Sensus Healthcare CEO Joseph C. Sardano Joins BirchBioMed Inc. Board of Directors

Mr. Sardano’s appointment as BirchBioMed’s first independent director is effective immediately.

August 13, 2018
·
2 min read
Pharm Country

Parents, Advocates, and Community to March to Purdue Pharma Headquarters to Protest

Organizers from Across the Country Will Join in Solemn Remembrance of Those Lost to OxyContin and Opioid Overdoses

August 13, 2018
·
2 min read
Business

Angie Aldinger Joins Taylor Strategy Partners as VP, Business Development

Aldinger’s appointment comes on the heels of several executive promotions to further fuel customer success.

August 13, 2018
·
2 min read
BioMidwest

Beltone Amaze™: A New, Amazingly Advanced and Powerful Hearing Aid

Available exclusively from Beltone, Amaze premium hearing aid system delivers excellent sound quality, unrivalled connectivity and rechargeability

August 13, 2018
·
3 min read
Policy

Regeneron Provides Regulatory Update on EYLEA® (aflibercept) Injection sBLA in Wet Age-Related Macular Degeneration

Regeneron Pharmaceuticals, Inc. announced that due to ongoing labeling discussions the U.S. Food and Drug Administration (FDA) has issued a complete response letter (CRL) regarding the supplemental Biologics License Application (sBLA) for EYLEA® (aflibercept)

August 13, 2018
·
10 min read
Business

Federal Street Acquisition Corp. to Combine with Universal Hospital Services

Combined Company to be Named “Agiliti, Inc.” and Listed on Nasdaq Stock Market

August 13, 2018
·
16 min read
Business

Nephros Appoints Oliver Spandow to its Board of Directors

Seasoned Executive Adds Significant Operational and M&A Expertise

August 13, 2018
·
3 min read
Policy

BioElectronics Applies for FDA’s Opioid Alternative Innovation Challenge Program

BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com, is pleased to announce that it has submitted an application to the U.S. Food and Drug Administration’s 2018 Opioid Innovation Challenge.

August 13, 2018
·
1 min read
Business

Haisco Pharmaceutical Group Co Ltd to Make a $10 Million Equity Investment in Pneuma Respiratory and Enters into a Distribution Agreement

Haisco Pharmaceutical Group is to receive rights to distribute Pneuma Respiratory’s pharmaceutical products in China.

August 13, 2018
·
2 min read
Business

FDA Accepts New Drug Application (NDA) to review Midazolam Nasal Spray, an investigational product for the acute treatment of seizure clusters

Midazolam Nasal Spray has also been granted Fast Track designation by the US FDA due to the high unmet need for patients and caregivers

August 13, 2018
·
8 min read